Esteve Quimica is a company developing, manufacturing, and marketing oral and injectable-non-sterile APIs (active pharmaceutical ingredient). It offers access to generic finished dosage forms (FDF) developed with in-house APIs. In addition, the company provides solutions including the development of chemical processes, technology to run cryogenic reactions, facilities for high-temperature synthesis, etc. Esteve Quimica operates within oncology, anti-diabetics, anti-platelets, and other fields.